MOYES JAY M
SEC Form 4 insider trading activity
MOYES JAY M has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including PBYI, SINT, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, MOYES JAY M is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, MOYES JAY M reported 1 open-market purchase totaling $3K in SINT and 1 open-market sale totaling $159K in PBYI. The largest disclosed transaction in the window is a sale of 22,000 PBYI shares on Jun 12, 2026, worth $159K.
Companies traded
Other insiders at PBYI
Insider Buying
$3K
reported purchases (SEC code P)
Insider Selling
$159K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MOYES JAY M made?
MOYES JAY M has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including PBYI, SINT since 2026.
Which companies does MOYES JAY M trade?
MOYES JAY M has filed SEC Form 4 disclosures for 2 companies, including PBYI, SINT.
When was MOYES JAY M's most recent SEC Form 4 filing?
MOYES JAY M's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is MOYES JAY M's total buy and sell value in the current window?
Inside the rolling retention window, MOYES JAY M bought $3K and sold $159K based on SEC Form 4 filings.
What was MOYES JAY M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 22,000 PBYI shares on 2026-06-12, worth $159K, per SEC Form 4 filings.